|
|
The BIT Life Sciences’ 3rd Annual World Cancer Congress 2010 is a China-based, interactive conference offering practicing oncologists with the newest research on epidemiologic, cancer molecular mechanisms, drug discovery, therapeutics development, diagnosis, clinical data, best practices, and new technologies that are directly applicable to the practice of cancer research and therapeutic discovery and development. The main motive of the conference is to spotlight on most significant and controversial topics on biology, diagnosis and treatment of breast cancer. The congress will feature educational Symposia, Plenary Lectures, co-current Sessions and Clinical Cases discussions. The experts will provide profound presentations wrapping the multidisciplinary approach to the practice of breast cancer management and fresh molecular-targeted therapies, with the amalgamation of molecular and biologic translational studies from the laboratory into clinical practice.
Visitor Profile
The targeted visitors in the event The BIT Life Sciences' Annual World Cancer Congress 2010 are:
- Decision Makers from Government & NGOs
- World Leading Scientists in Breast Oncology
- Pharmaceutical/Biotech Executives
- Hospital Clinicians and Practitioners
- Anti-breast Cancer Therapeutics Manufacturers
- Academic Researchers & Public Health & Advocators
- Breast Cancer Prevention Practitioners & Advocators
Exhibitor Profile
The profile for exhibit in the event The BIT Life Sciences' Annual World Cancer Congress 2010 comprises:
- Pharmaceutical companies
- Bio-tech companies
- Manufacturers of Life Science Research products
- Distributors of life science products
- Products/instruments Companies
- Service Providers for the pharmaceutical and biotech companies
- Companies manufacturing laboratory products
- Software companies with solutions/applications
Organizer
BIT Life Sciences
